C12N2760/12011 - CPC Classification
Classification description:
ssRNA viruses negative-sense; Details Bunyaviridae
Sub-classes:
- C12N2760/12021 » Viruses as such, e.g. new isolates, mutants or their genomic sequences 7
- C12N2760/12022 » New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes 24
- C12N2760/12023 » Virus like particles [VLP] 0
- C12N2760/12031 » Uses of virus other than therapeutic or vaccine, e.g. disinfectant 0
- C12N2760/12032 » Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent 0
- C12N2760/12033 » Use of viral protein as therapeutic agent other than vaccine, e.g. apoptosis inducing or anti-inflammatory 0
- C12N2760/12034 » Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein 26
- C12N2760/12041 » Use of virus, viral particle or viral elements as a vector 0
- C12N2760/12051 » Methods of production or purification of viral material 4
- C12N2760/12061 » Methods of inactivation or attenuation 5
- C12N2760/12071 » Demonstrated in vivo effect 2
- C12N2760/12088 » For redistribution 0
- C12N2760/12111 » Hantavirus, e.g. Hantaan virus 4
- C12N2760/12211 » Phlebovirus, e.g. Rift Valley fever virus 10